semaglutide anesthesia considerations New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Risks aGLP-1 receptor agonists & anesthesia:

In 2025, 36% of employers offered to cover GLP-1 drugs as a treatment for both obesity and diabetes, with about 55% covering diabetes alone

Our naturopaths use Plaquex IV Therapy in cardiovascular disease, liver dysfunction, Lyme disease, neurodegenerative conditions, and toxin exposure

The development of the hippocampus, a brain region implicated in learning, memory, and social behavior, is a key event in a normally developing fetus

While these medications are often safe when used independently, combining them can sometimes raise questions about potential interactions, side effects, or impacts on your existing health conditions

L- -

If you have questions about coverage or affordability, our staff is here to help you every step of the way